Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis.
about
In silico identification of potential key regulatory factors in smoking-induced lung cancer.Prognostic value of decreased FOXP1 protein expression in various tumors: a systematic review and meta-analysisSafety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study.Distinct global binding patterns of the Wilms tumor gene 1 (WT1) -KTS and +KTS isoforms in leukemic cells.Targeting of the WT191-138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination.Blocking the binding of WT1 to bcl-2 promoter by G-quadruplex ligand SYUIQ-FM05.Mesothelin Expression in Gastric Adenocarcinoma and Its Relation to Clinical OutcomesPhase 1/2 study of the WT1 peptide cancer vaccine WT4869 in patients with myelodysplastic syndrome.DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and -KTS isoforms-From initial observations to recent global genomic analyses.A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemia.Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future.WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short report.RNA activation technique and its applications in cancer research.Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma.Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma
P2860
Q33776567-9CBE372A-EDB9-4784-925B-74B521A4AB34Q37125561-35E26C51-BA6F-47F0-9B23-BCB9762073C6Q37675627-DD7DB698-3023-4CEB-92A7-A79FD121167BQ39405563-34579360-2ABF-4C6B-9500-42AED1B907BBQ40452198-47F9EF38-6394-4BEF-8ED9-BB863DC738A6Q41683272-AFAF3C41-8F1D-49CB-B0E8-E01271B06917Q41992584-62876DF3-7646-490B-8088-725B017B4AC1Q42693220-1271125C-3C97-4CE4-AF22-295EBC5B40B2Q47294532-26D383F3-713D-4DD1-BD11-75B9FB2FF58AQ47637581-F217ED56-B026-4965-80FA-8E204808BA74Q52676017-A6FF4837-C72B-46AE-A8E3-812D4FE0ACFCQ54638455-3897D50B-34D6-4D29-8172-319BBBAD444DQ55337892-6B76900B-DF5D-4C52-98D5-4A7D834B778DQ55629068-8D874E82-B8BD-4171-B334-C10FB2D491F9Q58603892-F48F6B68-1116-4BB9-B868-0D343A0D76F3
P2860
Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Wilms' tumor 1 (WT1) expressio ...... atic review and meta-analysis.
@ast
Wilms' tumor 1 (WT1) expressio ...... atic review and meta-analysis.
@en
type
label
Wilms' tumor 1 (WT1) expressio ...... atic review and meta-analysis.
@ast
Wilms' tumor 1 (WT1) expressio ...... atic review and meta-analysis.
@en
prefLabel
Wilms' tumor 1 (WT1) expressio ...... atic review and meta-analysis.
@ast
Wilms' tumor 1 (WT1) expressio ...... atic review and meta-analysis.
@en
P2093
P2860
P921
P356
P1433
P1476
Wilms' tumor 1 (WT1) expressio ...... matic review and meta-analysis
@en
P2093
P2860
P2888
P356
10.1038/SREP08924
P407
P50
P5008
P577
2015-03-09T00:00:00Z